The global anticoagulant rodenticides market size is expected to reach USD 921.56 million by 2030 according to a new study by Polaris Market Research. The report “Anticoagulant Rodenticides Market Share, Size, Trends, Industry Analysis Report, By Form (Pellets, Blocks, Powders & Sprays); By Application (Agriculture, Pest Control Companies, Warehouses, Urban Centers, Household, Others); By Product; By Region; Segment Forecast, 2022 - 2030” gives a detailed insight into current market dynamics and provides analysis on future market growth.
The increased demand for mosquito control solutions to reduce the growing rodent population and efforts to stop illness caused by them are driving the market expansion. For instance, Rentokil PCI provides a call-out solution for rats and other pest control issues in the home. Also, according to the CDC, rats and mice are responsible for the transmission of over 35 diseases worldwide. These infections are spread to people through direct communication with rodents, feces, urine, or saliva, or through rodent bites. Infections transmitted by rodents could also be transmitted to people indirectly via ticks, mites, or fleas eaten on an infected rat.
Have Questions? Request a sample or make an Inquiry before buying this report by clicking the link below: https://www.polarismarketresearch.com/industry-analysis/anticoagulant-rodenticides-market/request-for-sample
Effective rodent management outside the home is the major technique for preventing human exposure to rodent illnesses. This is accomplished by removing all food sources, closing even the slightest gaps in homes, and successfully capturing rodents in and around the residence. Further, the changing climatic circumstances are significant in the market as global warming changes the population dynamics of rodents and their habitats, as rats breed more prominently in warmer areas.
Climate change is causing a surge in rodent populations, a serious international public health concern. The hantavirus infection is becoming more sensitive to environmental factors. Rodent populations respond more quickly to favorable weather circumstances, such as excessive rainfall, which might directly or indirectly spread rodent-borne infections such as spirosis zoonotic bacterial disease with an undetermined but likely significant human and veterinary frequency.
Based on the product, the 1st generation anticoagulants rodenticides market segment accounted for the leading share in the market in 2021. Because of its capacity to break down faster than 2nd generation anticoagulants rodenticides, the first-generation rodenticides product type category accounted for a significant revenue share. The future market expansion of first and second-generation rodenticides, both quantity and income, is strongly related to consumer awareness of good manufacturing practices and government regulations.
Market players such as NEOGEN Corporation, Bayer AG, Bell Labs., Heranba Industries Ltd., Kalyani Industries Limited, BASF SE, Syngenta Crop Protection AG, PelGar International, Rentokil Initial plc, Liphatech, Inc., and UPL are key players operating in the global anticoagulant rodenticides industry.
In May 2021, BASF introduced Selontra, a novel rodenticide bait that it claims can reduce rodent infections in just seven days. The bait contains cholecalciferol, a novel active mechanism of action to which mice are not known to be resistant. Cholecalciferol has a rapid onset of action and stops mouse feeding within 24 hours. This reduces feed wastage and the biosecurity danger posed by rats in agriculture. Concerns about resistance to anticoagulant rodenticides baits necessitated the development of a new action to combat so-called "super rats" that had limited access to difenacoum and bromadiolone active ingredients, which are used in a variety of conventional baits.
Polaris Market Research has segmented the anticoagulant rodenticides market report based on product, form, application, and region:
Anticoagulant Rodenticides, Product Outlook (Revenue - USD Million, 2018 - 2030)
Anticoagulant Rodenticides, Form Outlook (Revenue - USD Million, 2018 - 2030)
Anticoagulant Rodenticides, Application Outlook (Revenue - USD Million, 2018 - 2030)
Anticoagulant Rodenticides, Regional Outlook (Revenue - USD Million, 2018 - 2030)